Search - tctmd.com

Displaying 341 - 360 of 501

Sort: Relevancy | Date

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

Presentation Physiology and Intravascular Imaging 2014

Update on Neoatherosclerosis: A Novel Form of Stent Failure

Presenter: Ziad A. Ali

March 27, 2014

News Daily News

Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS

Jason Kahn

February 20, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

Presentation

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Presenter: Martin Werner

February 19, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

February 12, 2014

News Daily News

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

January 06, 2014

News Daily News

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

December 30, 2013

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

Presentation

Drug-Eluting Balloons in The Coronary Circulation: Novel Findings and New Strategies

Presenter: Gregory A. Sgueglia

December 01, 2013

Presentation TCT 2013

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Presenter: Bernardo Cortese

October 31, 2013

Presentation TCT 2013

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Presenter: Martin Leon

October 29, 2013

Advertisement

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Update on Neoatherosclerosis: A Novel Form of Stent Failure

Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Drug-Eluting Balloons in The Coronary Circulation: Novel Findings and New Strategies

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content